MacroGenics
MGNX
#8794
Rank
NZ$0.42 B
Marketcap
NZ$6.66
Share price
5.35%
Change (1 day)
117.95%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$0.53 Billion

According to MacroGenics's latest financial reports the company's total liabilities are NZ$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.34 B34.6%
2024-12-31NZ$0.25 B11.97%
2023-12-31NZ$0.23 B5.72%
2022-12-31NZ$0.21 B55.77%
2021-12-31NZ$0.14 B21.91%
2020-12-31NZ$0.11 B-5.54%
2019-12-31NZ$0.12 B-8.64%
2018-12-31NZ$0.13 B26.6%
2017-12-31NZ$0.10 B71.26%
2016-12-31NZ$61.37 M-8.55%
2015-12-31NZ$67.11 M-0.03%
2014-12-31NZ$67.13 M17.71%
2013-12-31NZ$57.03 M-24.31%
2012-12-31NZ$75.34 M-26.64%
2011-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$206.05 B 38,123.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$193.16 B 35,731.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$149.59 B 27,649.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$67.03 B 12,334.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$156.48 B 28,927.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$116.38 B 21,489.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.39 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA